STL Volume 16 Number 1

STL Volume 16 Number 1
Purchase PDF for $2.79
Update on Drugs and Drug News

Update on Drugs and Drug News: January 2011

Update on drugs, approval dates, and comments. Calcipotriene/Calcipotriol0.005% foam (Sorilux™), Ceftaroline fosamil (Teflaro™) are covered as well as an update on Health Canada on the use of tacrolimus (Protopic®) for atopic dermatitis.

Current Effective Topical Therapies in the Management of Psoriasis

Topical therapy forms the cornerstone of treatment in the management of psoriasis. Topical options, vehicle advances, and treatment efficacy of several topicals are discussed for managing psoriasis.
image of silk fabric and dry skin

Cutaneous Side-effects of EGFR Inhibitors and Their Management

Epidermal growth factor receptor (EGFR) inhibitors are an increasingly important treatment option for metastasized cancer in patients. We present an overview of the various cutaneous side-effects associated with EGFR inhibition and discuss their respective therapeutic options.